U of T scientists use nanoparticles to improve chemotherapy response and boost anti-tumor immunity in breast cancer

Scientists at the University of Toronto’s Leslie Dan Faculty of Pharmacy have seen remarkable success combining tumor modulating nanoparticles with doxorubicin to enhance chemotherapy response in pre-clinical model breast cancer.

This combination approach also appears to boost anti-tumor immunity, contributing to the growing excitement surrounding immunotherapy as an avenue to treat cancer.

Read more


Related Articles


Comments